AUSTEDO Reviews (DEUTETRABENAZINE)

Average Rating: 2.5 (4 Ratings)

Filter Results

Compare AUSTEDO with similar:

 Type: Rx Drug

  

AUSTEDO  (DEUTETRABENAZINE):  Deutetrabenazine is used to decrease involuntary movements (chorea) caused by Huntington's disease. It is also used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). However, it is not a cure for the Huntington's disease or tardive dyskinesia. Reducing involuntary movements will help you take part in more of your normal daily activities. This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).   FDA Approval Date: 2017-04-03 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR AUSTEDOCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  tardive dyskinesia of the tongue worsening dyskinesia, insomnia, suicidal thoughts The experience was a total disaster for me. I have been off the drug for several days and am still having side effects. M 71 3 days
6 2X day
2/7/2023
 3  TD Tired.. constipation My symptoms are still there just not quite as bad F 62 6 months
30mg 2X day
8/29/2022
 5  hunting disease none. Each beer feels like 3 takes care of HD movements M 54 5 years
24 2X day
4/15/2022
Email
 1  Tardive dyskinesia Lip smacking body convulsions nausea Wish they would make something that would work and antipsychotics that did not cause this! F 29 0 days
24mg
8/26/2019
  

AUSTEDO  (DEUTETRABENAZINE):  Deutetrabenazine is used to decrease involuntary movements (chorea) caused by Huntington's disease. It is also used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). However, it is not a cure for the Huntington's disease or tardive dyskinesia. Reducing involuntary movements will help you take part in more of your normal daily activities. This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).   FDA Approval Date: 2017-04-03 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP